Subscribe To Our Free Newsletter |
Biocon jumps 4% on the back of strong Q2 performance
The stock had shed 16 per cent in Samvat 2079. So far in 2023, the stock has declined 9 per cent as against a near 7 per cent gain on the BSE benchmark.